$6.35
0.142.25%
At close: -
$6.21
-0.14-2.20%
After Hours: Dec 23, 4:00 PM EDT
Comments
Loading...
Design Therapeutics (DSGN) Forecast
NewsEarningsDesign Therapeutics (DSGN) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestDesign Therapeutics (NASDAQ:DSGN) Stock Quotes, Forecast and News Summary
Design Therapeutics Stock (NASDAQ: DSGN) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Design Therapeutics (DSGN) stock?
You can purchase shares of Design Therapeutics (NASDAQ:DSGN) through any online brokerage.
Who are Design Therapeutics (DSGN) competitors?
Other companies in Design Therapeutics’s space includes: Valneva (NASDAQ:VALN), Voyager Therapeutics (NASDAQ:VYGR), Korro Bio (NASDAQ:KRRO), Sage Therapeutics (NASDAQ:SAGE) and Tango Therapeutics (NASDAQ:TNGX).
What is the forecast, or price target, for Design Therapeutics (DSGN) stock?
Design Therapeutics has a consensus price target of $6.75.
What is the current price for Design Therapeutics (DSGN)?
The stock price for Design Therapeutics (NASDAQ: DSGN) is $6.21 last updated December 23, 2024 at 4:00 PM EST.
Does Design Therapeutics (DSGN) pay a dividend?
There are no upcoming dividends for Design Therapeutics.
When is Design Therapeutics (NASDAQ:DSGN) reporting earnings?
Design Therapeutics’s Q4 earnings are confirmed for Tuesday, March 18, 2025.
Is Design Therapeutics (DSGN) going to split?
There is no upcoming split for Design Therapeutics.
What sector and industry does Design Therapeutics (DSGN) operate in?
Design Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.